NCX 4016, a nitric oxide-releasing aspirin derivative, exhibits a significant antiproliferative effect and alters cell cycle progression in human colon adenocarcinoma cell lines

  • Anna Tesei, Luca Ricotti, Paola Ulivi, Laura Medri, Dino Amadori, Wainer Zoli
  • International Journal of Oncology, June 2003, Spandidos Publications
  • DOI: 10.3892/ijo.22.6.1297

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Dr Anna Tesei